Protillion Biosciences
Signal active
Organization
Contact Information
Overview
Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
About
Industries
Biotechnology, Biopharma, Genetics
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Protillion Biosciences headquartered in United States, North America, operates in the Biotechnology, Biopharma, Genetics sector. The company focuses on Biotechnology and has secured $216.0M in funding across 12 round(s). With a team of 11-50 employees, Protillion Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Protillion Biosciences, raised $18.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$18.0M
Details
1
Protillion Biosciences has raised a total of $18.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 18.0M |
Investors
Protillion Biosciences is funded by 5 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 18.0M |
| David R. Walt | - | FUNDING ROUND - David R. Walt | 18.0M |
| Protillion Biosciences | - | FUNDING ROUND - Protillion Biosciences | 18.0M |
| Illumina Ventures | - | FUNDING ROUND - Illumina Ventures | 18.0M |
Recent Activity
There is no recent news or activity for this profile.